|
1
|
Houston MS, Silverstein MD and Suman VJ:
Community-acquired lower respiratory tract infection in the
elderly: A community-based study of incidence and outcome. J Am
Board Fam Pract. 8:347–356. 1995.PubMed/NCBI
|
|
2
|
Jiang W, Yin F, Zhou W, Yan Y and Ji W:
Clinical significance of different virus load of human bocavirus in
patients with lower respiratory tract infection. Sci Rep.
6:202462016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chiricozzi E, Loberto N, Schiumarini D,
Samarani M, Mancini G, Tamanini A, Lippi G, Dechecchi MC, Bassi R,
Giussani P, et al: Sphingolipids role in the regulation of
inflammatory response: From leukocyte biology to bacterial
infection. J Leukoc Biol. 103:445–456. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Honda T, Uehara T, Matsumoto G, Arai S and
Sugano M: Neutrophil left shift and white blood cell count as
markers of bacterial infection. Clin Chim Acta. 457:46–53. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Muloiwa R, Dube FS, Nicol MP, Zar HJ and
Hussey GD: Incidence and diagnosis of pertussis in South African
children hospitalized with lower respiratory tract infection.
Pediatr Infect Dis J. 35:611–616. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu S, Jiang T, Zhang X, Zhou Y, Yi Z, Wang
Y, Zhao S, Wang M, Ming D and Chen S: Elizabethkingia anophelis
isolated from patients with multiple organ dysfunction syndrome and
lower respiratory tract infection: Report of two cases and
literature review. Front Microbiol. 8:3822017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mazur NI, Martinón-Torres F, Baraldi E,
Fauroux B, Greenough A, Heikkinen T, Manzoni P, Mejias A, Nair H,
Papadopoulos NG, et al: Respiratory Syncytial Virus Network
(ReSViNET): Lower respiratory tract infection caused by respiratory
syncytial virus: Current management and new therapeutics. Lancet
Respir Med. 3:888–900. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cohen C, Moyes J, Tempia S, Groome M,
Walaza S, Pretorius M, Naby F, Mekgoe O, Kahn K, von Gottberg A, et
al: Epidemiology of acute lower respiratory tract infection in
HIV-exposed uninfected infants. Pediatrics. 137:1372016. View Article : Google Scholar
|
|
9
|
Yoshihara K, Le MN, Okamoto M, Wadagni AC,
Nguyen HA, Toizumi M, Pham E, Suzuki M, Nguyen AT, Oshitani H, et
al: Association of RSV-A ON1 genotype with increased pediatric
acute lower respiratory tract infection in Vietnam. Sci Rep.
6:278562016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lodise TP Jr, Miller C, Patel N, Graves J
and McNutt LA: Identification of patients with Pseudomonas
aeruginosa respiratory tract infections at greatest risk of
infection with carbapenem-resistant isolates. Infect Control Hosp
Epidemiol. 28:959–965. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Volturo GA, Low DE and Aghababian R:
Managing acute lower respiratory tract infections in an era of
antibacterial resistance. Am J Emerg Med. 24:329–342. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kraus EM, Pelzl S, Szecsenyi J and Laux G:
Antibiotic prescribing for acute lower respiratory tract infections
(LRTI)-guideline adherence in the German primary care setting: An
analysis of routine data. PLoS One. 12:e01745842017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shah AJ, Mulla SA and Revdiwala SB:
Neonatal sepsis: High antibiotic resistance of the bacterial
pathogens in a neonatal intensive care unit of a tertiary care
hospital. J Clin Neonatol. 1:72–75. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Abdul-Aziz MH, Lipman J, Mouton JW, Hope
WW and Roberts JA: Applying pharmacokinetic/pharmacodynamic
principles in critically ill patients: Optimizing efficacy and
reducing resistance development. Semin Respir Crit Care Med.
36:136–153. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Serisier DJ: Inhaled antibiotics for lower
respiratory tract infections: Focus on ciprofloxacin. Drugs Today
(Barc). 48:339–351. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Di Marco F, Braido F, Santus P, Scichilone
N and Blasi F: The role of cefditoren in the treatment of lower
community-acquired respiratory tract infections (LRTIs): From
bacterial eradication to reduced lung inflammation and epithelial
damage. Eur Rev Med Pharmacol Sci. 18:321–332. 2014.PubMed/NCBI
|
|
17
|
Thompson AA, Dickinson RS, Murphy F,
Thomson JP, Marriott HM, Tavares A, Willson J, Williams L, Lewis A,
Mirchandani A, et al: Hypoxia determines survival outcomes of
bacterial infection through HIF-1alpha dependent re-programming of
leukocyte metabolism. Sci Immunol. 2:eaa128612017. View Article : Google Scholar
|
|
18
|
Kim JH, Lee JY, Cho HR, Lee JS, Ryu JM and
Lee J: High concentration of C-reactive protein is associated with
serious bacterial infection in previously healthy children aged 3
to 36 months with fever and extreme leukocytosis. Pediatr Emerg
Care. 1:2017.
|
|
19
|
Durán A, González A, Delgado L, Mosquera J
and Valero N: Serum level of C-reactive protein is not a parameter
to determine the difference between viral and atypical bacterial
infections. J Med Virol. 88:351–355. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ben Amar J, Zaibi H, Bouzid K, Azzabi S,
Bacca MA, Dahari B and Aouina H: Role of procalcitonin and
c-reactive protein levels: A diagnostic tool in lower respiratory
tract infections. Tunis Med. 94:176–180. 2016.PubMed/NCBI
|
